PureTech Health (NASDAQ:PRTC) Trading Up 3.5% – Time to Buy?

PureTech Health plc (NASDAQ:PRTC) shares traded up 3.5% during trading on Monday . The stock traded as high as $16.82 and last traded at $17.30. 650 shares were traded during trading, a decline of 83% from the average session volume of 3,900 shares. The stock had previously closed at $16.71.

PureTech Health Trading Up 2.0 %

The stock has a 50-day moving average price of $18.23 and a two-hundred day moving average price of $19.67.

Hedge Funds Weigh In On PureTech Health

An institutional investor recently bought a new position in PureTech Health stock. Birch Hill Investment Advisors LLC bought a new stake in shares of PureTech Health plc (NASDAQ:PRTC) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor bought 302,000 shares of the company’s stock, valued at approximately $5,575,000. Birch Hill Investment Advisors LLC owned about 1.26% of PureTech Health as of its most recent filing with the Securities and Exchange Commission. Institutional investors and hedge funds own 0.04% of the company’s stock.

About PureTech Health

PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies.